Physician profile
Kellie Wo
NPI 1043888282
$2,250.49
in general payments reported to CMS, 2019-2025
14 companies · $2,127 in 2025
The $2,127 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.29 · 2024: $104 · 2025: $2,127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,231.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $249.71 | 2025 | Jardiance |
| Amgen INC. | $227.54 | 2025 | Evenity |
| Novo Nordisk INC | $221.34 | 2025 | Ozempic |
| Glaxosmithkline, LLC. | $183.52 | 2024-2025 | Arexvy, Bexsero |
| Astrazeneca Pharmaceuticals LP | $163.51 | 2024-2025 | Airsupra |
| Ars Pharmaceuticals Operations, INC. | $150.62 | 2025 | Neffy |
| Insulet Corporation | $150.00 | 2025 | Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $144.29 | 2021-2025 | |
| Dexcom, INC. | $141.24 | 2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Intuitive Surgical, INC. | $128.35 | 2025 | |
| Abbott Laboratories | $126.66 | 2025 | Freestyle Libre 3 |
| Abbvie INC. | $125.00 | 2025 | |
| Gilead Sciences, INC. | $121.85 | 2025 | Yeztugo |
| Merck Sharp & Dohme LLC | $116.86 | 2025 | Capvaxive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellie Wo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.